Clinical Study

GenoWhite™: Advanced Spot Correcting Peptide

Format: PDF file | Document type: Clinical Study | Promoted Content

This Clinical Study has been written by Corum , and any views and opinions expressed do not necessarily reflect those of www.cosmeticsdesign-asia.com

GenoWhiteTM: Advanced Spot Correcting Peptide

GenoWhiteTM​ is a new and patented spot-correcting technology with fast dermal penetration feature. A series of extensive studies have proven that this whitening peptide, other than possessing excellent safety and stability profile, can also target multiple steps of skin pigmentation. Only a small amount of GenoWhiteTM​ can bring up outstanding performances, including melanin reduction and inhibition of melanin-generating enzymes, tyrosinase (-100%), TRP-1 (-42.1%) and TRP-2 (-91.9%). Genetically, GenoWhiteTM​ functions to diminish the melanin-promoting transcription factor MITF (-39%). It can significantly reduce the pigmenting cross-talk by inhibiting endothelin-1(-92.7%) and stem cell factor (-61.3%). It is also able to interrupt the melanosome transport system and in turn prevent the melanosome distribution. All these multiple targeting benefits of GenoWhiteTM​ are the key to its excellent efficacy, which is clinically proven to correct the spots, improve radiance and even skin complexion in just 14 days.

Latest content from Corum

Epi-On enhances skin recovery through Epigenetics

Content provided by Corum

Epi-On: Satisfying male skin needs

Epi-On is a patented active ingredient for skin recovery. It is clinically proven to reduce inflamed skin and accelerate skin healing for irritated and sensitive skin.

Related resources from Corum

Supplier info centre